1-{3-[4-(13-{[4-(1-Methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}tridecyl)piperidin-1-yl]propyl}-1,2,3,4-tetrahydroquinolin-2-one (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 1-{3-[4-(13-{[4-(1-Methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}tridecyl)piperidin-1-yl]propyl}-1,2,3,4-tetrahydroquinolin-2-one's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
1-{3-[4-(13-{[4-(1-Methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}tridecyl)piperidin-1-yl]propyl}-1,2,3,4-tetrahydroquinolin-2-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Muscarinic acetylcholine receptor M2 Protein (Entity type)	Ki
1-{3-[4-(13-{[4-(1-Methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}tridecyl)piperidin-1-yl]propyl}-1,2,3,4-tetrahydroquinolin-2-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Muscarinic acetylcholine receptor M4 Protein (Entity type)	Ki
1-{3-[4-(13-{[4-(1-Methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}tridecyl)piperidin-1-yl]propyl}-1,2,3,4-tetrahydroquinolin-2-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Muscarinic acetylcholine receptor M5 Protein (Entity type)	Ki
1-{3-[4-(13-{[4-(1-Methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}tridecyl)piperidin-1-yl]propyl}-1,2,3,4-tetrahydroquinolin-2-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Muscarinic acetylcholine receptor M3 Protein (Entity type)	Ki
1-{3-[4-(13-{[4-(1-Methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl]oxy}tridecyl)piperidin-1-yl]propyl}-1,2,3,4-tetrahydroquinolin-2-one Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Muscarinic acetylcholine receptor M1 Protein (Entity type)	Ki